BioSig Technologies, Inc., following its merger with Streamex Exchange Corporation, has secured up to $1.1 billion in growth financing from a leading institutional investor. The transaction, led by Cantor Fitzgerald & Co., Clear Street LLC, and Needham & Company, LLC, aims to position BioSig as one of Nasdaq's largest public holders of gold bullion. This strategic move will support the launch of a gold-backed treasury management strategy and accelerate the company's efforts in real-world asset tokenization for the $142 trillion commodities market. With this financing, BioSig is set to transform global finance by integrating gold and commodities on-chain, enhancing liquidity, transparency, and accessibility.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。